NCT00741715View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia

PHASE3TerminatedINTERVENTIONAL
Enrollment

1,736

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Hypercholesterolemia
Interventions
DRUG

AVE5530

oral administration once daily in the evening with dinner

DRUG

atorvastatin

oral administration once daily in the evening with dinner

DRUG

placebo

oral administration once daily in the evening with dinner

Trial Locations (2)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, San Juan

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY